New approaches to antidepressant drug discovery: beyond monoamines (Q28293089)

Nature Reviews Neuroscience

Europe PubMed Central

title

New approaches to antidepressant drug discovery: beyond monoamines (English)

0 references

0 references

2

Eric J Nestler

0 references

Olivier Berton

series ordinal

1

object named as

Olivier Berton

0 references

language of work or name

English

0 references

publication date

February 2006

0 references

published in

0 references

volume

7

0 references

page(s)

137-51

0 references

issue

2

0 references

cites work

Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress

1 reference

Vasopressin V1b receptor knockout reduces aggressive behavior in male mice

21 April 2017

1 reference

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

21 April 2017

1 reference

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

21 April 2017

1 reference

Essential role of brain-derived neurotrophic factor in adult hippocampal function

21 April 2017

1 reference

Metabotropic glutamate receptors as novel targets for anxiety and stress disorders

21 April 2017

1 reference

Molecular characterization of the melanin-concentrating-hormone receptor

21 April 2017

1 reference

Coordination of circadian timing in mammals

21 April 2017

1 reference

Regulation of dopaminergic transmission and cocaine reward by the Clock gene

21 April 2017

1 reference

Altered patterns of sleep and behavioral adaptability in NPAS2-deficient mice

21 April 2017

1 reference

Epigenetic programming by maternal behavior

21 April 2017

1 reference

Stress and the brain: from adaptation to disease

21 April 2017

1 reference

Deep brain stimulation for treatment-resistant depression

21 April 2017

1 reference

Modulation of anxiety through blockade of anandamide hydrolysis

21 April 2017

1 reference

Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum

21 April 2017

1 reference

The cellular neurobiology of depression

21 April 2017

1 reference

Neurobiology of depression

21 January 2018

1 reference

Hypercortisolemia and depression.

21 January 2018

1 reference

The mesolimbic dopamine reward circuit in depression

21 January 2018

1 reference

Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders

21 January 2018

1 reference

Elevated concentrations of CRF in the locus coeruleus of depressed subjects

21 January 2018

1 reference

Positron emission tomography imaging in depression: a neural systems perspective

21 January 2018

1 reference

Depression: what we can learn from postmortem studies

21 January 2018

1 reference

Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders

21 January 2018

1 reference

Role of neurotrophic factors in the etiology and treatment of mood disorders

21 January 2018

1 reference

Stress hormones: good and bad.

21 January 2018

1 reference

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

21 January 2018

1 reference

The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and disease.

21 January 2018

1 reference

Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety

21 January 2018

1 reference

New vistas on amygdala networks in conditioned fear

21 January 2018

1 reference

Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders

21 January 2018

1 reference

Endocrinology of the stress response.

21 January 2018

1 reference

CRF and CRF receptors: role in stress responsivity and other behaviors

21 January 2018

1 reference

The pharmacology of DMP696 and DMP904, non-peptidergic CRF1 receptor antagonists.

21 January 2018

1 reference

Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation.

21 January 2018

1 reference

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

21 January 2018

1 reference

Future antidepressants: what is in the pipeline and what is missing?

21 January 2018

1 reference

Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model.

21 January 2018

1 reference

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

21 January 2018

1 reference

Neuroendocrine basis of social recognition

21 January 2018

1 reference

Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior

21 January 2018

1 reference

Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability

21 January 2018

1 reference

Restructuring the neuronal stress response with anti-glucocorticoid gene delivery

21 January 2018

1 reference

Gene therapy to bet on: protecting neurons from stress hormones

21 January 2018

1 reference

Clinical and biological effects of mifepristone treatment for psychotic depression

21 January 2018

1 reference

Strategies for producing faster acting antidepressants.

21 January 2018

1 reference

Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial

21 January 2018

1 reference

Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms?

21 January 2018

1 reference

Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs

21 January 2018

1 reference

Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats

21 January 2018

1 reference

First dual NK(1) antagonists-serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressants

21 January 2018

1 reference

Increased neurogenesis and brain‐derived neurotrophic factor in neurokinin‐1 receptor gene knockout mice

21 January 2018

1 reference

Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist L-000760735 are associated with altered neurofilaments and synaptic remodeling

21 January 2018

1 reference

Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice

21 January 2018

1 reference

Changes in signaling pathways regulating neuroplasticity induced by neurokinin 1 receptor knockout

21 January 2018

1 reference

Chronic psychosocial stress in tree shrews: effect of the substance P (NK1 receptor) antagonist L-760735 and clomipramine on endocrine and behavioral parameters.

21 January 2018

1 reference

A molecular and cellular theory of depression

21 January 2018

1 reference

Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression.

21 January 2018

1 reference

Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress

21 January 2018

1 reference

The fibroblast growth factor system and mood disorders.

21 January 2018

1 reference

Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect.

21 January 2018

1 reference

Targeting the CREB pathway for memory enhancers

21 January 2018

1 reference

Genetic approaches to memory storage

21 January 2018

1 reference

Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline.

21 January 2018

1 reference

Clinical studies implementing glutamate neurotransmission in mood disorders

21 January 2018

1 reference

Glutamate and depression: clinical and preclinical studies

21 January 2018

1 reference

AMPA receptor potentiators as novel antidepressants

21 January 2018

1 reference

The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance.

21 January 2018

1 reference

Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist

21 January 2018

1 reference

Genetic inactivation of melanin-concentrating hormone receptor subtype 1 (MCHR1) in mice exerts anxiolytic-like behavioral effects

21 January 2018

1 reference

Finding new clock components: past and future.

21 January 2018

1 reference

Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum

21 January 2018

1 reference

Impaired cued and contextual memory in NPAS2-deficient mice

21 January 2018

1 reference

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

21 January 2018

1 reference

Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection

21 January 2018

1 reference

Preclinical models: status of basic research in depression

21 January 2018

1 reference

Gene therapy for psychiatric disorders

21 January 2018

1 reference

Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats

21 January 2018

1 reference

Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists

21 January 2018

1 reference

Endocannabinoid system and stress and anxiety responses.

21 January 2018

1 reference

CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents

21 January 2018

1 reference

Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents

21 January 2018

1 reference

Cytokines as mediators of depression: what can we learn from animal studies?

21 January 2018

1 reference

Chronic administration of tianeptine balances lipopolysaccharide-induced expression of cytokines in the spleen and hypothalamus of rats.

21 January 2018

1 reference

Antidepressant action of agomelatine (S 20098) in a transgenic mouse model

21 January 2018

1 reference

Phenotypic assessment of galanin overexpressing and galanin receptor R1 knockout mice in the tail suspension test for depression-related behavior

21 January 2018

1 reference

Epigenetic mechanisms in memory formation.

21 January 2018

1 reference

Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration.

21 January 2018

1 reference

Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures.

21 January 2018

1 reference

Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior

21 January 2018

1 reference

Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication

21 January 2018

1 reference

Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression.

31 March 2020

1 reference

TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting

31 March 2020

1 reference

Lower sensitivity to stress and altered monoaminergic neuronal function in mice lacking the NMDA receptor epsilon 4 subunit.

31 March 2020

1 reference

Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response

31 March 2020

1 reference